Global Contract Pharmaceutical Manufacturing Market Professional Survey Report 2018

Table of Contents

Global Contract Pharmaceutical Manufacturing Market Professional Survey Report 2017

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Contract Pharmaceutical Manufacturing Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Active Pharmaceutical Ingredients (API) Market Performance (Volume)
  • 2.1.2 Finished Dosage Formulations (FDF) Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Active Pharmaceutical Ingredients (API) Market Performance (Value)
  • 2.1.2 Finished Dosage Formulations (FDF) Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Big Pharma Market Performance (Volume)
  • 3.1.2 Specialty/Midsize Market Performance (Volume)
  • 3.1.3 Generics Market Performance (Volume)
  • 3.1.4 Other Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Catalent
  • 4.1.1 Catalent Profiles
  • 4.1.2 Catalent Product Information
  • 4.1.3 Catalent Contract Pharmaceutical Manufacturing Business Performance
  • 4.1.4 Catalent Contract Pharmaceutical Manufacturing Business Development and Market Status
• 4.2 DPx
  • 4.2.1 DPx Profiles
  • 4.2.2 DPx Product Information
  • 4.2.3 DPx Contract Pharmaceutical Manufacturing Business Performance
  • 4.2.4 DPx Contract Pharmaceutical Manufacturing Business Development and Market Status
• 4.3 Lonza
  • 4.3.1 Lonza Profiles
  • 4.3.2 Lonza Product Information
  • 4.3.3 Lonza Contract Pharmaceutical Manufacturing Business Performance
  • 4.3.4 Lonza Contract Pharmaceutical Manufacturing Business Development and Market Status
• 4.4 Piramal Healthcare
  • 4.4.1 Piramal Healthcare Profiles
  • 4.4.2 Piramal Healthcare Product Information
  • 4.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Business Performance
  • 4.4.4 Piramal Healthcare Contract Pharmaceutical Manufacturing Business Development and Market Status
• 4.5 Aenova
  • 4.5.1 Aenova Profiles
  • 4.5.2 Aenova Product Information
  • 4.5.3 Aenova Contract Pharmaceutical Manufacturing Business Performance
  • 4.5.4 Aenova Contract Pharmaceutical Manufacturing Business Development and Market Status
• 4.6 Jubilant
  • 4.6.1 Jubilant Profiles
  • 4.6.2 Jubilant Product Information
  • 4.6.3 Jubilant Contract Pharmaceutical Manufacturing Business Performance
  • 4.6.4 Jubilant Contract Pharmaceutical Manufacturing Business Development and Market Status
• 4.7 Famar
  • 4.7.1 Famar Profiles
  • 4.7.2 Famar Product Information
  • 4.7.3 Famar Contract Pharmaceutical Manufacturing Business Performance
  • 4.7.4 Famar Contract Pharmaceutical Manufacturing Business Development and Market Status
• 4.8 Boehringer Ingelheim
  • 4.8.1 Boehringer Ingelheim Profiles
  • 4.8.2 Boehringer Ingelheim Product Information
  • 4.8.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Business Performance
  • 4.8.4 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Business Development and Market Status
• 4.9 Fareva Holding
  • 4.9.1 Fareva Holding Profiles
  • 4.9.2 Fareva Holding Product Information
  • 4.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Business Performance
  • 4.9.4 Fareva Holding Contract Pharmaceutical Manufacturing Business Development and Market Status
• 4.10 AbbVie
  • 4.10.1 AbbVie Profiles
  • 4.10.2 AbbVie Product Information
  • 4.10.3 AbbVie Contract Pharmaceutical Manufacturing Business Performance
  • 4.10.4 AbbVie Contract Pharmaceutical Manufacturing Business Development and Market Status
• 4.11 Nipro Corp
• 4.12 Vetter
• 4.13 Lonza
• 4.14 Piramal Healthcare
• 4.15 Aenova

5 Market Performance for Manufacturers

• 5.1 Global Contract Pharmaceutical Manufacturing Capacity (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Global Contract Pharmaceutical Manufacturing Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.3 Global Contract Pharmaceutical Manufacturing Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.4 Global Contract Pharmaceutical Manufacturing Price (USD/Unit) of Manufacturers 2013-2018
• 5.5 Global Contract Pharmaceutical Manufacturing Gross Margin of Manufacturers 2013-2018
• 5.6 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 China Market Performance for Manufacturers
  • 6.1.1 China Contract Pharmaceutical Manufacturing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 China Contract Pharmaceutical Manufacturing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 China Contract Pharmaceutical Manufacturing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 China Contract Pharmaceutical Manufacturing Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 USA Market Performance for Manufacturers
  • 6.2.1 USA Contract Pharmaceutical Manufacturing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 USA Contract Pharmaceutical Manufacturing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 USA Contract Pharmaceutical Manufacturing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 USA Contract Pharmaceutical Manufacturing Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 Europe Market Performance for Manufacturers
  • 6.3.1 Europe Contract Pharmaceutical Manufacturing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 Europe Contract Pharmaceutical Manufacturing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 Europe Contract Pharmaceutical Manufacturing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 Europe Contract Pharmaceutical Manufacturing Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 Japan Market Performance for Manufacturers
  • 6.4.1 Japan Contract Pharmaceutical Manufacturing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 Japan Contract Pharmaceutical Manufacturing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 Japan Contract Pharmaceutical Manufacturing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 Japan Contract Pharmaceutical Manufacturing Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration
• 6.5 Korea Market Performance for Manufacturers
  • 6.5.1 Korea Contract Pharmaceutical Manufacturing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.5.2 Korea Contract Pharmaceutical Manufacturing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.5.3 Korea Contract Pharmaceutical Manufacturing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.5.4 Korea Contract Pharmaceutical Manufacturing Gross Margin of Manufacturers 2013-2018
  • 6.5.5 Market Concentration
• 6.6 India Market Performance for Manufacturers
  • 6.6.1 India Contract Pharmaceutical Manufacturing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.6.2 India Contract Pharmaceutical Manufacturing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.6.3 India Contract Pharmaceutical Manufacturing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.6.4 India Contract Pharmaceutical Manufacturing Gross Margin of Manufacturers 2013-2018
  • 6.6.5 Market Concentration
• 6.7 Southeast Asia Market Performance for Manufacturers
  • 6.7.1 Southeast Asia Contract Pharmaceutical Manufacturing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.7.2 Southeast Asia Contract Pharmaceutical Manufacturing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.7.3 Southeast Asia Contract Pharmaceutical Manufacturing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.7.4 Southeast Asia Contract Pharmaceutical Manufacturing Gross Margin of Manufacturers 2013-2018
  • 6.7.5 Market Concentration
• 6.8 South America Market Performance for Manufacturers
  • 6.8.1 South America Contract Pharmaceutical Manufacturing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.8.2 South America Contract Pharmaceutical Manufacturing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.8.3 South America Contract Pharmaceutical Manufacturing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.8.4 South America Contract Pharmaceutical Manufacturing Gross Margin of Manufacturers 2013-2018
  • 6.8.5 Market Concentration

7 Global Contract Pharmaceutical Manufacturing Market Performance (Sales Point)

• 7.1 Global Contract Pharmaceutical Manufacturing Capacity (K Units) and Market Share by Regions 2013-2018
• 7.2 Global Contract Pharmaceutical Manufacturing Sales (K Units) and Market Share by Regions 2013-2018
• 7.3 Global Contract Pharmaceutical Manufacturing Revenue (M USD) and Market Share by Regions 2013-2018
• 7.4 Global Contract Pharmaceutical Manufacturing Price (USD/Unit) by Regions 2013-2018
• 7.5 Global Contract Pharmaceutical Manufacturing Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 Global Contract Pharmaceutical Manufacturing Capacity and Growth, Sales Value and Growth Rate2013-2018
• 8.2 China Contract Pharmaceutical Manufacturing Capacity and Growth, Sales Value and Growth Rate2013-2018
• 8.3 USA Contract Pharmaceutical Manufacturing Capacity and Growth, Sales Value and Growth Rate2013-2018
• 8.4 Europe Contract Pharmaceutical Manufacturing Capacity and Growth, Sales Value and Growth Rate2013-2018
• 8.5 Japan Contract Pharmaceutical Manufacturing Capacity and Growth, Sales Value and Growth Rate2013-2018
• 8.6 Korea Contract Pharmaceutical Manufacturing Capacity and Growth, Sales Value and Growth Rate2013-2018
• 8.7 India Contract Pharmaceutical Manufacturing Capacity and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Southeast Asia Contract Pharmaceutical Manufacturing Capacity and Growth, Sales Value and Growth Rate2013-2018
• 8.9 Southeast Asia Contract Pharmaceutical Manufacturing Capacity and Growth, Sales Value and Growth Rate2013-2018

9 Development Trend for Regions (Sales Point)

• 9.1 Global Contract Pharmaceutical Manufacturing Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.2 China Contract Pharmaceutical Manufacturing Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.3 USA Contract Pharmaceutical Manufacturing Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.4 Europe Contract Pharmaceutical Manufacturing Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.5 Japan Contract Pharmaceutical Manufacturing Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.6 Korea Contract Pharmaceutical Manufacturing Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.7 India Contract Pharmaceutical Manufacturing Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.8 Southeast Asia Contract Pharmaceutical Manufacturing Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.9 South America Contract Pharmaceutical Manufacturing Sales and Growth, Sales Value and Growth Rate2013-2018

10 Upstream Source, Technology and Cost

• 10.1 Upstream Source
• 10.2 Technology
• 10.3 Cost

11 Channel Analysis

• 11.1 Market Channel
• 11.2 Distributors

12 Consumer Analysis

• 12.1 Big Pharma Industry
• 12.2 Specialty/Midsize Industry
• 12.3 Generics Industry

13 Market Forecast 2019-2024

• 13.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 13.1.1 Global Contract Pharmaceutical Manufacturing Capacity (K Units) and Share by Regions 2019-2024
  • 13.1.2 Global Contract Pharmaceutical Manufacturing Capacity (K Units), Sales (K Units) and Growth Rate 2019-2024
  • 13.1.3 China Contract Pharmaceutical Manufacturing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.4 USA Contract Pharmaceutical Manufacturing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.5 Europe Contract Pharmaceutical Manufacturing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.6 Japan Contract Pharmaceutical Manufacturing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.7 Korea Contract Pharmaceutical Manufacturing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.8 India Contract Pharmaceutical Manufacturing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.9 Southeast Asia Contract Pharmaceutical Manufacturing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.10 South America Contract Pharmaceutical Manufacturing Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 13.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 13.3.1 Overall Market Performance
  • 13.3.2 Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.3.3 Finished Dosage Formulations (FDF) Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 13.4 Sales by Application 2019-2024
  • 13.4.1 Overall Market Performance
  • 13.4.2 Big Pharma Sales and and Growth Rate 2019-2024
  • 13.4.3 Specialty/Midsize Sales and and Growth Rate 2019-2024
  • 13.4.4 Generics Sales and and Growth Rate 2019-2024
  • 13.4.5 Other Sales and and Growth Rate 2019-2024
• 13.5 Price (USD/Unit) and Gross Profit
  • 13.5.1 Global Contract Pharmaceutical Manufacturing Price (USD/Unit) Trend 2019-2024
  • 13.5.2 Global Contract Pharmaceutical Manufacturing Gross Profit Trend 2019-2024

14 Conclusion